Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
PubMed PMID: 22243494
1-trifluoro-2-methylpropan-2-yl)-1
as gastric pump inhibitor
Metastatic Castration-Resistant Prostate Cancer: Critical Review of MDV-3100
Pimavanserin - CAS# 706779-91-1 Size:Solid 10 mg PubMed PMID: 22243494Pimavanserin, also known as ACP 103, is an inverse agonist on the serotonin receptor subtype 5 HT2A, with 40x selectivity over 5 HT2C, and no significant affinity or activity at 5 HT2B or dopamine receptors. Pimavanserin is a novel drug candidate for Parkinson's psychosis. Parkinson's disease psychosis (PDP) is a condition that may develop in up to 60 % of Parkinson's patients, and is a major reason for nursing home placement for those affected.
US$ 16588.00
US$ 24150.00
US$ 20794.80
US$ 13912.50
US$ 6298.95
US$ 5773.95
US$ 27562.50
US$ 6036.45
US$ 5850.00